Back to search

Netherlands· NL-6c3029544358

Trientine Waymade 200 mg harde capsules

A trientine product containing trientinedihydrochloride, registered in Netherlands by Waymade B.V.. The same ATC class is registered in 19 of our 19 countries.

ATC A16AX12

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedTrientine Waymade 200 mg harde capsul…ATCA16AX12REGISTER NO.NL-6c3029544358PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Trientine is registered in 19 of 19 countries.

Countries holding a registration under ATC A16AX12 (trientine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 11 of them publish a price we can compare per daily dose

Trientine · ATC A16AX12

19 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of trientine costs, country by country.

Normalised to the WHO defined daily dose (0.45 g), the median price runs from $97.54 in Switzerland to $186.45 in Italy — a ×1.9 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Trientine · price per daily dose (0.45 g)

USD · FX 28 Sept 2026

  • IT Italy$186.45
  • CH Switzerland$97.54
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
TRIENTINEDIHYDROCHLORIDE
Manufacturer
Waymade B.V.
Country
Netherlands (NL)
ATC code
A16AX12
ATC class
Trientine
Defined daily dose
0.45 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    127814

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

35 interactions on record for trientine.

Graded by severity as the source publishes them — 31 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Trientine · interactions on record

35 records

  • 31 moderate
  • 4 minor

Most severe, free to view

  • Magnesium carbonateA02AA01moderate
  • Magnesium oxideA02AA02moderate
  • Magnesium hydroxideA02AA04moderate
  • Kombinationen von AluminiumsalzenA02AB10moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Trientine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All trientine products

Authorised across Europe · EMA

The same active substance is authorised in 19 EEA countries. Names it is sold under:

  • Austria · Aveleris, Trientin
  • Belgium · Aveleris
  • Czechia · Trientine Tillomed
  • Germany · Aveleris, Trientin Waymade
  • Denmark · Trientin Waymade, Trientine Tillomed
  • Spain · Trientina
  • Finland · Trientine Tillomed, Trientine Waymade
  • France · Trientine Tillomed, Trientine Waymade
  • United Kingdom (Northern Ireland) · Trientine, Trientine Dihydrochloride Tillomed
  • Greece · Trientine Tillomed, Trientine Waymade
  • Ireland · Trientine Tillomed, Trientine Tillomed Pharma
  • Iceland · Cufence, Cuprior
  • Italy · Trientina Ideogen, Trientina Waymade
  • Liechtenstein · Cufence, Cuprior
  • Luxembourg · Aveleris
  • Norway · Cufence, Cuprior
  • Portugal · Trientina Tillomed, Trientina Waymade
  • Sweden · Trientine Tillomed, Trientine Waymade
  • Slovakia · Trientine Tillomed

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f81518da-051d-4ab8-b7af-f480a5946001
GET /v1/drugs/f81518da-051d-4ab8-b7af-f480a5946001?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h127814_smpc.pdf",
  "strength": null,
  "atc_label": "Trientine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg127814",
  "excipients": [
    "AMMONIA (E 527)",
    "GELATINE (E 441)",
    "IJZEROXIDE ZWART (E 172)",
    "KALIUMHYDROXIDE (E 525)",
    "PROPYLEENGLYCOL (E 1520)",
    "SCHELLAK (E 904)",
    "STEARINEZUUR (E 570)",
    "TITAANDIOXIDE (E 171)",
    "ZWARTE INKT"
  ],
  "substances": [
    "TRIENTINEDIHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h127814.pdf",
  "authorised_at": "2022/11/03",
  "procedure_number": "DE/H/6991/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "127814",
  "additional_monitoring": "N"
}

See everything about trientine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.